nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylate-sodium—Salicylamide—Zileuton—asthma	0.333	1	CrCrCtD
Salicylate-sodium—PTGS2—asthma	0.213	1	CbGaD
Salicylate-sodium—PTGS1—Zileuton—asthma	0.0708	0.265	CbGbCtD
Salicylate-sodium—PTGS1—Zafirlukast—asthma	0.0623	0.233	CbGbCtD
Salicylate-sodium—PTGS1—Montelukast—asthma	0.0456	0.171	CbGbCtD
Salicylate-sodium—PTGS2—Triamcinolone—asthma	0.0374	0.14	CbGbCtD
Salicylate-sodium—PTGS2—Betamethasone—asthma	0.0321	0.12	CbGbCtD
Salicylate-sodium—PTGS2—Dexamethasone—asthma	0.0187	0.07	CbGbCtD
Salicylate-sodium—Mesalazine—ALOX5—asthma	0.000724	0.35	CrCbGaD
Salicylate-sodium—PTGS1—Eicosanoid Synthesis—ALOX5AP—asthma	0.000701	0.0173	CbGpPWpGaD
Salicylate-sodium—PTGS2—Prostaglandin Synthesis and Regulation—PTGDR—asthma	0.000689	0.017	CbGpPWpGaD
Salicylate-sodium—PTGS1—Arachidonic acid metabolism—LTA4H—asthma	0.00062	0.0153	CbGpPWpGaD
Salicylate-sodium—PTGS1—Eicosanoid Synthesis—ALOX5—asthma	0.000596	0.0147	CbGpPWpGaD
Salicylate-sodium—PTGS2—Arachidonic acid metabolism—LTC4S—asthma	0.000568	0.014	CbGpPWpGaD
Salicylate-sodium—PTGS2—Eicosanoid Synthesis—ALOX5AP—asthma	0.000556	0.0138	CbGpPWpGaD
Salicylate-sodium—PTGS2—Eicosanoid Synthesis—ALOX15—asthma	0.000556	0.0138	CbGpPWpGaD
Salicylate-sodium—PTGS2—Arachidonic acid metabolism—LTA4H—asthma	0.000492	0.0122	CbGpPWpGaD
Salicylate-sodium—PTGS2—Eicosanoid Synthesis—ALOX5—asthma	0.000473	0.0117	CbGpPWpGaD
Salicylate-sodium—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NOS1—asthma	0.000466	0.0115	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TBX21—asthma	0.000458	0.0113	CbGpPWpGaD
Salicylate-sodium—PTGS1—Overview of nanoparticle effects—HMOX1—asthma	0.000427	0.0106	CbGpPWpGaD
Salicylate-sodium—PTGS1—Prostaglandin Synthesis and Regulation—EDNRB—asthma	0.00041	0.0102	CbGpPWpGaD
Salicylate-sodium—PTGS1—Arachidonic acid metabolism—ALOX15—asthma	0.000389	0.00964	CbGpPWpGaD
Salicylate-sodium—PTGS1—Arachidonic acid metabolism—ALOX5AP—asthma	0.000389	0.00964	CbGpPWpGaD
Salicylate-sodium—PTGS2—Fluocinonide—Ciclesonide—asthma	0.000343	0.111	CbGdCrCtD
Salicylate-sodium—PTGS2—Overview of nanoparticle effects—HMOX1—asthma	0.000339	0.00839	CbGpPWpGaD
Salicylate-sodium—PTGS2—Fluocinonide—Fluticasone furoate—asthma	0.000336	0.109	CbGdCrCtD
Salicylate-sodium—PTGS1—Overview of nanoparticle effects—CRP—asthma	0.000335	0.00828	CbGpPWpGaD
Salicylate-sodium—PTGS1—Arachidonic acid metabolism—ALOX5—asthma	0.000331	0.00819	CbGpPWpGaD
Salicylate-sodium—PTGS2—Prostaglandin Synthesis and Regulation—EDNRB—asthma	0.000326	0.00806	CbGpPWpGaD
Salicylate-sodium—PTGS2—Fluocinonide—Fluticasone Propionate—asthma	0.000313	0.101	CbGdCrCtD
Salicylate-sodium—PTGS2—Arachidonic acid metabolism—ALOX15—asthma	0.000309	0.00765	CbGpPWpGaD
Salicylate-sodium—PTGS2—Arachidonic acid metabolism—ALOX5AP—asthma	0.000309	0.00765	CbGpPWpGaD
Salicylate-sodium—PTGS1—Overview of nanoparticle effects—FN1—asthma	0.000309	0.00764	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL3—asthma	0.000287	0.00709	CbGpPWpGaD
Salicylate-sodium—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—asthma	0.000286	0.00709	CbGpPWpGaD
Salicylate-sodium—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—asthma	0.000279	0.00691	CbGpPWpGaD
Salicylate-sodium—PTGS1—Prostaglandin Synthesis and Regulation—PLA2G4A—asthma	0.000276	0.00683	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—asthma	0.000272	0.00673	CbGpPWpGaD
Salicylate-sodium—PTGS2—S1P1 pathway—PDGFB—asthma	0.000272	0.00672	CbGpPWpGaD
Salicylate-sodium—PTGS2—Overview of nanoparticle effects—CRP—asthma	0.000266	0.00657	CbGpPWpGaD
Salicylate-sodium—PTGS2—Arachidonic acid metabolism—ALOX5—asthma	0.000263	0.0065	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—ALOX5AP—asthma	0.000248	0.00613	CbGpPWpGaD
Salicylate-sodium—PTGS2—Overview of nanoparticle effects—FN1—asthma	0.000245	0.00606	CbGpPWpGaD
Salicylate-sodium—Magnesium salicylate—PTGS2—asthma	0.000237	0.115	CrCbGaD
Salicylate-sodium—PTGS1—Overview of nanoparticle effects—BCL2—asthma	0.000236	0.00584	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—LTB4R—asthma	0.00023	0.0057	CbGpPWpGaD
Salicylate-sodium—PTGS2—Fluocinonide—Beclomethasone—asthma	0.00023	0.0745	CbGdCrCtD
Salicylate-sodium—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—asthma	0.000225	0.00557	CbGpPWpGaD
Salicylate-sodium—PTGS1—Overview of nanoparticle effects—PTGS2—asthma	0.000224	0.00555	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcium signaling in the CD4+ TCR pathway—CSF2—asthma	0.000223	0.00551	CbGpPWpGaD
Salicylate-sodium—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—asthma	0.000222	0.00549	CbGpPWpGaD
Salicylate-sodium—PTGS2—Fluocinonide—Budesonide—asthma	0.000221	0.0714	CbGdCrCtD
Salicylate-sodium—PTGS2—Prostaglandin Synthesis and Regulation—PLA2G4A—asthma	0.000219	0.00542	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—asthma	0.000219	0.00542	CbGpPWpGaD
Salicylate-sodium—PTGS2—Fluocinonide—Flunisolide—asthma	0.000218	0.0705	CbGdCrCtD
Salicylate-sodium—PTGS1—Overview of nanoparticle effects—CXCL8—asthma	0.000218	0.00538	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—ARG1—asthma	0.000217	0.00536	CbGpPWpGaD
Salicylate-sodium—PTGS1—Phase 1 - Functionalization of compounds—ALDH2—asthma	0.000212	0.00525	CbGpPWpGaD
Salicylate-sodium—Magnesium salicylate—ALB—asthma	0.000211	0.102	CrCbGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—ALOX5—asthma	0.000211	0.00521	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—GATA3—asthma	0.00021	0.0052	CbGpPWpGaD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—NQO1—asthma	0.000203	0.00503	CbGpPWpGaD
Salicylate-sodium—PTGS2—Fluticasone Propionate—Fluticasone furoate—asthma	0.000203	0.0656	CbGdCrCtD
Salicylate-sodium—Salsalate—PTGS2—asthma	0.000202	0.0975	CrCbGaD
Salicylate-sodium—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—asthma	0.000201	0.00497	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL5—asthma	0.000199	0.00493	CbGpPWpGaD
Salicylate-sodium—PTGS2—S1P1 pathway—RHOA—asthma	0.000197	0.00487	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—ALOX5AP—asthma	0.000197	0.00487	CbGpPWpGaD
Salicylate-sodium—PTGS2—Signaling mediated by p38-alpha and p38-beta—PLA2G4A—asthma	0.000194	0.00479	CbGpPWpGaD
Salicylate-sodium—PTGS2—Overview of nanoparticle effects—BCL2—asthma	0.000187	0.00464	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—asthma	0.000187	0.00463	CbGpPWpGaD
Salicylate-sodium—PTGS1—Eicosanoid Synthesis—PTGS2—asthma	0.000186	0.0046	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL3—asthma	0.000185	0.00459	CbGpPWpGaD
Salicylate-sodium—PTGS1—Arachidonic acid metabolism—PLA2G4A—asthma	0.000184	0.00454	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—MIF—asthma	0.000181	0.00447	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—MYB—asthma	0.00018	0.00445	CbGpPWpGaD
Salicylate-sodium—PTGS2—Fluocinonide—Mometasone—asthma	0.000179	0.0577	CbGdCrCtD
Salicylate-sodium—Mesalazine—PTGS2—asthma	0.000175	0.0846	CrCbGaD
Salicylate-sodium—PTGS2—Overview of nanoparticle effects—CXCL8—asthma	0.000173	0.00427	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—ALOX5—asthma	0.000167	0.00414	CbGpPWpGaD
Salicylate-sodium—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—asthma	0.000161	0.00398	CbGpPWpGaD
Salicylate-sodium—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—asthma	0.000156	0.00385	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—IL1R1—asthma	0.000156	0.00385	CbGpPWpGaD
Salicylate-sodium—PTGS1—Overview of nanoparticle effects—TNF—asthma	0.000151	0.00375	CbGpPWpGaD
Salicylate-sodium—Acetylsalicylic acid—PTGS2—asthma	0.000151	0.0728	CrCbGaD
Salicylate-sodium—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—asthma	0.000149	0.00368	CbGpPWpGaD
Salicylate-sodium—PTGS2—Arachidonic acid metabolism—PLA2G4A—asthma	0.000146	0.0036	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—asthma	0.000146	0.0036	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CSF2—asthma	0.000144	0.00356	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—asthma	0.000142	0.00351	CbGpPWpGaD
Salicylate-sodium—PTGS2—S1P1 pathway—VEGFA—asthma	0.00014	0.00347	CbGpPWpGaD
Salicylate-sodium—PTGS2—Fluticasone Propionate—Beclomethasone—asthma	0.000139	0.0449	CbGdCrCtD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—GATA3—asthma	0.000139	0.00343	CbGpPWpGaD
Salicylate-sodium—Acetylsalicylic acid—ALB—asthma	0.000134	0.0649	CrCbGaD
Salicylate-sodium—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—asthma	0.000132	0.00328	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—TACR1—asthma	0.000132	0.00327	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—C5—asthma	0.000132	0.00327	CbGpPWpGaD
Salicylate-sodium—PTGS2—Fluticasone Propionate—Flunisolide—asthma	0.000131	0.0425	CbGdCrCtD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—CDK2—asthma	0.00013	0.00322	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—asthma	0.00013	0.00321	CbGpPWpGaD
Salicylate-sodium—Salicylic acid—PTGS2—asthma	0.000124	0.06	CrCbGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—CAT—asthma	0.000124	0.00306	CbGpPWpGaD
Salicylate-sodium—PTGS1—Overview of nanoparticle effects—IL6—asthma	0.000122	0.00302	CbGpPWpGaD
Salicylate-sodium—PTGS2—Overview of nanoparticle effects—TNF—asthma	0.00012	0.00297	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—RAD50—asthma	0.000119	0.00294	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—asthma	0.000118	0.00291	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—ALDH2—asthma	0.000113	0.00279	CbGpPWpGaD
Salicylate-sodium—Salicylic acid—ALB—asthma	0.000111	0.0534	CrCbGaD
Salicylate-sodium—PTGS2—Fluticasone Propionate—Mometasone—asthma	0.000108	0.0348	CbGdCrCtD
Salicylate-sodium—PTGS1—Biological oxidations—GSTT1—asthma	0.000107	0.00265	CbGpPWpGaD
Salicylate-sodium—PTGS2—Fluocinonide—Methylprednisolone—asthma	0.000107	0.0345	CbGdCrCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—IL1R1—asthma	0.000106	0.00262	CbGpPWpGaD
Salicylate-sodium—PTGS2—Fluocinonide—Dexamethasone—asthma	0.000105	0.0339	CbGdCrCtD
Salicylate-sodium—PTGS2—Fluocinonide—Betamethasone—asthma	0.000105	0.0339	CbGdCrCtD
Salicylate-sodium—PTGS1—Arachidonic acid metabolism—PTGS2—asthma	0.000103	0.00256	CbGpPWpGaD
Salicylate-sodium—PTGS2—Fluocinonide—Triamcinolone—asthma	0.000103	0.0332	CbGdCrCtD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—LTC4S—asthma	0.000102	0.00253	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—CRP—asthma	9.82e-05	0.00243	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—CAT—asthma	9.81e-05	0.00243	CbGpPWpGaD
Salicylate-sodium—PTGS2—Overview of nanoparticle effects—IL6—asthma	9.7e-05	0.0024	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—GSTM1—asthma	9.62e-05	0.00238	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—NOS1—asthma	9.42e-05	0.00233	CbGpPWpGaD
Salicylate-sodium—PTGS1—Phase 1 - Functionalization of compounds—POMC—asthma	9.09e-05	0.00225	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—ICAM1—asthma	9.02e-05	0.00223	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—LTA4H—asthma	8.86e-05	0.00219	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—asthma	8.57e-05	0.00212	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—CXCL10—asthma	8.55e-05	0.00211	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—LTC4S—asthma	8.12e-05	0.00201	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—CCL2—asthma	8.07e-05	0.002	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—asthma	7.97e-05	0.00197	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—CRP—asthma	7.79e-05	0.00193	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—BDNF—asthma	7.68e-05	0.0019	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—asthma	7.61e-05	0.00188	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—SERPINE1—asthma	7.54e-05	0.00186	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—ALB—asthma	7.52e-05	0.00186	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—GSTP1—asthma	7.43e-05	0.00184	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—ICAM1—asthma	7.16e-05	0.00177	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—IL4—asthma	7.13e-05	0.00176	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—LTA4H—asthma	7.04e-05	0.00174	CbGpPWpGaD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—asthma	6.92e-05	0.00171	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—IFNG—asthma	6.87e-05	0.0017	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—GSTM1—asthma	6.83e-05	0.00169	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—PTGS2—asthma	6.58e-05	0.00163	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—asthma	6.46e-05	0.0016	CbGpPWpGaD
Salicylate-sodium—PTGS2—Fluticasone Propionate—Methylprednisolone—asthma	6.44e-05	0.0208	CbGdCrCtD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—CCL2—asthma	6.41e-05	0.00159	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—asthma	6.34e-05	0.00157	CbGpPWpGaD
Salicylate-sodium—PTGS2—Fluticasone Propionate—Dexamethasone—asthma	6.33e-05	0.0205	CbGdCrCtD
Salicylate-sodium—PTGS2—Fluticasone Propionate—Betamethasone—asthma	6.33e-05	0.0205	CbGdCrCtD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—EGFR—asthma	6.22e-05	0.00154	CbGpPWpGaD
Salicylate-sodium—PTGS2—Fluticasone Propionate—Triamcinolone—asthma	6.19e-05	0.02	CbGdCrCtD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—IL1B—asthma	6.12e-05	0.00151	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—CDK2—asthma	6.12e-05	0.00151	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—LEP—asthma	6.03e-05	0.00149	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—SERPINE1—asthma	5.98e-05	0.00148	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—ALB—asthma	5.97e-05	0.00148	CbGpPWpGaD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—TNF—asthma	5.93e-05	0.00147	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—TLR4—asthma	5.91e-05	0.00146	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—BCL2—asthma	5.71e-05	0.00141	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—asthma	5.7e-05	0.00141	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—ICAM1—asthma	5.66e-05	0.0014	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—NOS2—asthma	5.62e-05	0.00139	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	5.57e-05	0.00138	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—ALOX15—asthma	5.57e-05	0.00138	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—asthma	5.54e-05	0.00137	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—CD4—asthma	5.46e-05	0.00135	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—IFNG—asthma	5.45e-05	0.00135	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CHAT—asthma	5.31e-05	0.00131	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—asthma	5.22e-05	0.00129	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—CCL2—asthma	5.07e-05	0.00125	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—PLA2G4A—asthma	4.99e-05	0.00123	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—IL1B—asthma	4.86e-05	0.0012	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—POMC—asthma	4.83e-05	0.00119	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—ALOX5—asthma	4.73e-05	0.00117	CbGpPWpGaD
Salicylate-sodium—Asthenia—Budesonide—asthma	4.58e-05	0.000324	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—RHOA—asthma	4.56e-05	0.00113	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—LTC4S—asthma	4.55e-05	0.00113	CbGpPWpGaD
Salicylate-sodium—Erythema—Hydrocortisone—asthma	4.52e-05	0.00032	CcSEcCtD
Salicylate-sodium—Dizziness—Montelukast—asthma	4.52e-05	0.00032	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CARM1—asthma	4.52e-05	0.00112	CbGpPWpGaD
Salicylate-sodium—Pruritus—Budesonide—asthma	4.51e-05	0.000319	CcSEcCtD
Salicylate-sodium—Diarrhoea—Salbutamol—asthma	4.5e-05	0.000319	CcSEcCtD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—TNF—asthma	4.44e-05	0.0011	CbGpPWpGaD
Salicylate-sodium—Vomiting—Formoterol—asthma	4.43e-05	0.000314	CcSEcCtD
Salicylate-sodium—Vomiting—Arformoterol—asthma	4.43e-05	0.000314	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—ALOX15—asthma	4.42e-05	0.00109	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	4.42e-05	0.00109	CbGpPWpGaD
Salicylate-sodium—Hallucination—Betamethasone—asthma	4.41e-05	0.000312	CcSEcCtD
Salicylate-sodium—Hallucination—Dexamethasone—asthma	4.41e-05	0.000312	CcSEcCtD
Salicylate-sodium—Nausea—Mometasone—asthma	4.41e-05	0.000312	CcSEcCtD
Salicylate-sodium—Rash—Arformoterol—asthma	4.4e-05	0.000311	CcSEcCtD
Salicylate-sodium—Rash—Formoterol—asthma	4.4e-05	0.000311	CcSEcCtD
Salicylate-sodium—Dermatitis—Formoterol—asthma	4.39e-05	0.000311	CcSEcCtD
Salicylate-sodium—Dermatitis—Arformoterol—asthma	4.39e-05	0.000311	CcSEcCtD
Salicylate-sodium—Weight increased—Prednisone—asthma	4.39e-05	0.000311	CcSEcCtD
Salicylate-sodium—Headache—Arformoterol—asthma	4.37e-05	0.000309	CcSEcCtD
Salicylate-sodium—Headache—Formoterol—asthma	4.37e-05	0.000309	CcSEcCtD
Salicylate-sodium—Arrhythmia—Triamcinolone—asthma	4.37e-05	0.000309	CcSEcCtD
Salicylate-sodium—Diarrhoea—Budesonide—asthma	4.36e-05	0.000309	CcSEcCtD
Salicylate-sodium—Vision blurred—Prednisolone—asthma	4.36e-05	0.000309	CcSEcCtD
Salicylate-sodium—Arrhythmia—Methylprednisolone—asthma	4.36e-05	0.000308	CcSEcCtD
Salicylate-sodium—Dizziness—Salbutamol—asthma	4.35e-05	0.000308	CcSEcCtD
Salicylate-sodium—Vomiting—Montelukast—asthma	4.34e-05	0.000307	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—IFNG—asthma	4.31e-05	0.00107	CbGpPWpGaD
Salicylate-sodium—Rash—Montelukast—asthma	4.31e-05	0.000305	CcSEcCtD
Salicylate-sodium—Dermatitis—Montelukast—asthma	4.3e-05	0.000304	CcSEcCtD
Salicylate-sodium—Headache—Montelukast—asthma	4.28e-05	0.000303	CcSEcCtD
Salicylate-sodium—Erythema—Triamcinolone—asthma	4.26e-05	0.000301	CcSEcCtD
Salicylate-sodium—Erythema—Methylprednisolone—asthma	4.25e-05	0.0003	CcSEcCtD
Salicylate-sodium—Acute coronary syndrome—Prednisone—asthma	4.24e-05	0.0003	CcSEcCtD
Salicylate-sodium—Myocardial infarction—Prednisone—asthma	4.22e-05	0.000298	CcSEcCtD
Salicylate-sodium—Dizziness—Budesonide—asthma	4.22e-05	0.000298	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CHAT—asthma	4.22e-05	0.00104	CbGpPWpGaD
Salicylate-sodium—Vomiting—Salbutamol—asthma	4.19e-05	0.000296	CcSEcCtD
Salicylate-sodium—Dysgeusia—Triamcinolone—asthma	4.17e-05	0.000295	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CDK2—asthma	4.16e-05	0.00103	CbGpPWpGaD
Salicylate-sodium—Rash—Salbutamol—asthma	4.15e-05	0.000294	CcSEcCtD
Salicylate-sodium—Syncope—Prednisolone—asthma	4.15e-05	0.000294	CcSEcCtD
Salicylate-sodium—Dermatitis—Salbutamol—asthma	4.15e-05	0.000293	CcSEcCtD
Salicylate-sodium—Nausea—Arformoterol—asthma	4.14e-05	0.000293	CcSEcCtD
Salicylate-sodium—Nausea—Formoterol—asthma	4.14e-05	0.000293	CcSEcCtD
Salicylate-sodium—Headache—Salbutamol—asthma	4.12e-05	0.000292	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Prednisolone—asthma	4.07e-05	0.000288	CcSEcCtD
Salicylate-sodium—Nausea—Montelukast—asthma	4.06e-05	0.000287	CcSEcCtD
Salicylate-sodium—Vomiting—Budesonide—asthma	4.05e-05	0.000287	CcSEcCtD
Salicylate-sodium—Syncope—Hydrocortisone—asthma	4.05e-05	0.000287	CcSEcCtD
Salicylate-sodium—Rash—Budesonide—asthma	4.02e-05	0.000285	CcSEcCtD
Salicylate-sodium—Dermatitis—Budesonide—asthma	4.02e-05	0.000284	CcSEcCtD
Salicylate-sodium—Convulsion—Prednisolone—asthma	4.01e-05	0.000284	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—CXCL8—asthma	4.01e-05	0.000991	CbGpPWpGaD
Salicylate-sodium—Headache—Budesonide—asthma	4e-05	0.000283	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Hydrocortisone—asthma	3.97e-05	0.000281	CcSEcCtD
Salicylate-sodium—Arrhythmia—Betamethasone—asthma	3.96e-05	0.00028	CcSEcCtD
Salicylate-sodium—Arrhythmia—Dexamethasone—asthma	3.96e-05	0.00028	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—LTA4H—asthma	3.95e-05	0.000977	CbGpPWpGaD
Salicylate-sodium—Convulsion—Hydrocortisone—asthma	3.92e-05	0.000277	CcSEcCtD
Salicylate-sodium—Nausea—Salbutamol—asthma	3.91e-05	0.000277	CcSEcCtD
Salicylate-sodium—Erythema—Dexamethasone—asthma	3.86e-05	0.000273	CcSEcCtD
Salicylate-sodium—Erythema—Betamethasone—asthma	3.86e-05	0.000273	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—IL1B—asthma	3.84e-05	0.000951	CbGpPWpGaD
Salicylate-sodium—Hallucination—Prednisone—asthma	3.84e-05	0.000272	CcSEcCtD
Salicylate-sodium—Anxiety—Hydrocortisone—asthma	3.83e-05	0.000271	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—IL2—asthma	3.83e-05	0.000948	CbGpPWpGaD
Salicylate-sodium—Syncope—Triamcinolone—asthma	3.82e-05	0.00027	CcSEcCtD
Salicylate-sodium—Syncope—Methylprednisolone—asthma	3.81e-05	0.000269	CcSEcCtD
Salicylate-sodium—Nausea—Budesonide—asthma	3.79e-05	0.000268	CcSEcCtD
Salicylate-sodium—Oedema—Prednisolone—asthma	3.78e-05	0.000267	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Prednisolone—asthma	3.78e-05	0.000267	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—ALOX5—asthma	3.76e-05	0.00093	CbGpPWpGaD
Salicylate-sodium—Loss of consciousness—Triamcinolone—asthma	3.74e-05	0.000265	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Methylprednisolone—asthma	3.73e-05	0.000264	CcSEcCtD
Salicylate-sodium—Shock—Prednisolone—asthma	3.72e-05	0.000263	CcSEcCtD
Salicylate-sodium—Oedema—Hydrocortisone—asthma	3.69e-05	0.000261	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Hydrocortisone—asthma	3.69e-05	0.000261	CcSEcCtD
Salicylate-sodium—Convulsion—Triamcinolone—asthma	3.69e-05	0.000261	CcSEcCtD
Salicylate-sodium—Tachycardia—Prednisolone—asthma	3.69e-05	0.000261	CcSEcCtD
Salicylate-sodium—Convulsion—Methylprednisolone—asthma	3.68e-05	0.00026	CcSEcCtD
Salicylate-sodium—Infection—Hydrocortisone—asthma	3.66e-05	0.000259	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Prednisolone—asthma	3.65e-05	0.000258	CcSEcCtD
Salicylate-sodium—Shock—Hydrocortisone—asthma	3.63e-05	0.000257	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—MMP9—asthma	3.62e-05	0.000897	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—LTC4S—asthma	3.61e-05	0.000894	CbGpPWpGaD
Salicylate-sodium—Anxiety—Methylprednisolone—asthma	3.6e-05	0.000255	CcSEcCtD
Salicylate-sodium—Tachycardia—Hydrocortisone—asthma	3.6e-05	0.000255	CcSEcCtD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—IL6—asthma	3.59e-05	0.000887	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CARM1—asthma	3.58e-05	0.000887	CbGpPWpGaD
Salicylate-sodium—Hyperhidrosis—Hydrocortisone—asthma	3.57e-05	0.000252	CcSEcCtD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—TNF—asthma	3.53e-05	0.000873	CbGpPWpGaD
Salicylate-sodium—Anorexia—Hydrocortisone—asthma	3.52e-05	0.000249	CcSEcCtD
Salicylate-sodium—Confusional state—Methylprednisolone—asthma	3.49e-05	0.000247	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Triamcinolone—asthma	3.47e-05	0.000246	CcSEcCtD
Salicylate-sodium—Oedema—Triamcinolone—asthma	3.47e-05	0.000246	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Methylprednisolone—asthma	3.47e-05	0.000245	CcSEcCtD
Salicylate-sodium—Syncope—Dexamethasone—asthma	3.46e-05	0.000245	CcSEcCtD
Salicylate-sodium—Syncope—Betamethasone—asthma	3.46e-05	0.000245	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—ARG1—asthma	3.45e-05	0.000854	CbGpPWpGaD
Salicylate-sodium—Arrhythmia—Prednisone—asthma	3.45e-05	0.000244	CcSEcCtD
Salicylate-sodium—Infection—Triamcinolone—asthma	3.45e-05	0.000244	CcSEcCtD
Salicylate-sodium—Hypotension—Hydrocortisone—asthma	3.45e-05	0.000244	CcSEcCtD
Salicylate-sodium—Infection—Methylprednisolone—asthma	3.44e-05	0.000244	CcSEcCtD
Salicylate-sodium—Shock—Triamcinolone—asthma	3.42e-05	0.000242	CcSEcCtD
Salicylate-sodium—Shock—Methylprednisolone—asthma	3.41e-05	0.000241	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Betamethasone—asthma	3.39e-05	0.00024	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Dexamethasone—asthma	3.39e-05	0.00024	CcSEcCtD
Salicylate-sodium—Paraesthesia—Prednisolone—asthma	3.39e-05	0.00024	CcSEcCtD
Salicylate-sodium—Tachycardia—Triamcinolone—asthma	3.39e-05	0.00024	CcSEcCtD
Salicylate-sodium—Tachycardia—Methylprednisolone—asthma	3.38e-05	0.000239	CcSEcCtD
Salicylate-sodium—Erythema—Prednisone—asthma	3.36e-05	0.000238	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Triamcinolone—asthma	3.36e-05	0.000238	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Methylprednisolone—asthma	3.35e-05	0.000237	CcSEcCtD
Salicylate-sodium—Convulsion—Betamethasone—asthma	3.35e-05	0.000237	CcSEcCtD
Salicylate-sodium—Convulsion—Dexamethasone—asthma	3.35e-05	0.000237	CcSEcCtD
Salicylate-sodium—Paraesthesia—Hydrocortisone—asthma	3.31e-05	0.000234	CcSEcCtD
Salicylate-sodium—Anxiety—Dexamethasone—asthma	3.28e-05	0.000232	CcSEcCtD
Salicylate-sodium—Anxiety—Betamethasone—asthma	3.28e-05	0.000232	CcSEcCtD
Salicylate-sodium—Dyspepsia—Hydrocortisone—asthma	3.25e-05	0.00023	CcSEcCtD
Salicylate-sodium—Hypotension—Methylprednisolone—asthma	3.24e-05	0.000229	CcSEcCtD
Salicylate-sodium—Pain—Prednisolone—asthma	3.23e-05	0.000229	CcSEcCtD
Salicylate-sodium—Decreased appetite—Hydrocortisone—asthma	3.21e-05	0.000227	CcSEcCtD
Salicylate-sodium—Fatigue—Hydrocortisone—asthma	3.18e-05	0.000225	CcSEcCtD
Salicylate-sodium—Vision blurred—Prednisone—asthma	3.17e-05	0.000224	CcSEcCtD
Salicylate-sodium—Pain—Hydrocortisone—asthma	3.15e-05	0.000223	CcSEcCtD
Salicylate-sodium—Oedema—Betamethasone—asthma	3.15e-05	0.000223	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Dexamethasone—asthma	3.15e-05	0.000223	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Betamethasone—asthma	3.15e-05	0.000223	CcSEcCtD
Salicylate-sodium—Oedema—Dexamethasone—asthma	3.15e-05	0.000223	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—LTA4H—asthma	3.13e-05	0.000775	CbGpPWpGaD
Salicylate-sodium—Infection—Betamethasone—asthma	3.13e-05	0.000222	CcSEcCtD
Salicylate-sodium—Infection—Dexamethasone—asthma	3.13e-05	0.000222	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—ALDH7A1—asthma	3.12e-05	0.000772	CbGpPWpGaD
Salicylate-sodium—Paraesthesia—Triamcinolone—asthma	3.12e-05	0.000221	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Prednisolone—asthma	3.11e-05	0.00022	CcSEcCtD
Salicylate-sodium—Paraesthesia—Methylprednisolone—asthma	3.11e-05	0.00022	CcSEcCtD
Salicylate-sodium—Shock—Betamethasone—asthma	3.1e-05	0.000219	CcSEcCtD
Salicylate-sodium—Shock—Dexamethasone—asthma	3.1e-05	0.000219	CcSEcCtD
Salicylate-sodium—Dyspnoea—Triamcinolone—asthma	3.1e-05	0.000219	CcSEcCtD
Salicylate-sodium—Tachycardia—Dexamethasone—asthma	3.08e-05	0.000218	CcSEcCtD
Salicylate-sodium—Tachycardia—Betamethasone—asthma	3.08e-05	0.000218	CcSEcCtD
Salicylate-sodium—Dyspepsia—Triamcinolone—asthma	3.06e-05	0.000216	CcSEcCtD
Salicylate-sodium—Dyspepsia—Methylprednisolone—asthma	3.05e-05	0.000216	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Dexamethasone—asthma	3.05e-05	0.000216	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Betamethasone—asthma	3.05e-05	0.000216	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Hydrocortisone—asthma	3.04e-05	0.000215	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Hydrocortisone—asthma	3.02e-05	0.000213	CcSEcCtD
Salicylate-sodium—Syncope—Prednisone—asthma	3.02e-05	0.000213	CcSEcCtD
Salicylate-sodium—Anorexia—Dexamethasone—asthma	3e-05	0.000213	CcSEcCtD
Salicylate-sodium—Anorexia—Betamethasone—asthma	3e-05	0.000213	CcSEcCtD
Salicylate-sodium—Urticaria—Prednisolone—asthma	3e-05	0.000212	CcSEcCtD
Salicylate-sodium—Fatigue—Triamcinolone—asthma	2.99e-05	0.000212	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—ARG2—asthma	2.99e-05	0.00074	CbGpPWpGaD
Salicylate-sodium—Fatigue—Methylprednisolone—asthma	2.99e-05	0.000211	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—TGFB1—asthma	2.99e-05	0.000739	CbGpPWpGaD
Salicylate-sodium—Pain—Triamcinolone—asthma	2.97e-05	0.00021	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—asthma	2.96e-05	0.000732	CbGpPWpGaD
Salicylate-sodium—Loss of consciousness—Prednisone—asthma	2.96e-05	0.000209	CcSEcCtD
Salicylate-sodium—Hypotension—Dexamethasone—asthma	2.94e-05	0.000208	CcSEcCtD
Salicylate-sodium—Hypotension—Betamethasone—asthma	2.94e-05	0.000208	CcSEcCtD
Salicylate-sodium—Urticaria—Hydrocortisone—asthma	2.93e-05	0.000207	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—EGFR—asthma	2.93e-05	0.000725	CbGpPWpGaD
Salicylate-sodium—Body temperature increased—Hydrocortisone—asthma	2.92e-05	0.000206	CcSEcCtD
Salicylate-sodium—Abdominal pain—Hydrocortisone—asthma	2.92e-05	0.000206	CcSEcCtD
Salicylate-sodium—Convulsion—Prednisone—asthma	2.91e-05	0.000206	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Triamcinolone—asthma	2.86e-05	0.000203	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Methylprednisolone—asthma	2.86e-05	0.000202	CcSEcCtD
Salicylate-sodium—Anxiety—Prednisone—asthma	2.85e-05	0.000202	CcSEcCtD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—IL6—asthma	2.85e-05	0.000704	CbGpPWpGaD
Salicylate-sodium—Gastrointestinal pain—Methylprednisolone—asthma	2.83e-05	0.000201	CcSEcCtD
Salicylate-sodium—Paraesthesia—Betamethasone—asthma	2.83e-05	0.0002	CcSEcCtD
Salicylate-sodium—Paraesthesia—Dexamethasone—asthma	2.83e-05	0.0002	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—TNF—asthma	2.79e-05	0.00069	CbGpPWpGaD
Salicylate-sodium—Hypersensitivity—Prednisolone—asthma	2.78e-05	0.000197	CcSEcCtD
Salicylate-sodium—Dyspepsia—Betamethasone—asthma	2.77e-05	0.000196	CcSEcCtD
Salicylate-sodium—Dyspepsia—Dexamethasone—asthma	2.77e-05	0.000196	CcSEcCtD
Salicylate-sodium—Urticaria—Triamcinolone—asthma	2.76e-05	0.000195	CcSEcCtD
Salicylate-sodium—Urticaria—Methylprednisolone—asthma	2.75e-05	0.000195	CcSEcCtD
Salicylate-sodium—Body temperature increased—Triamcinolone—asthma	2.75e-05	0.000194	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Prednisone—asthma	2.74e-05	0.000194	CcSEcCtD
Salicylate-sodium—Oedema—Prednisone—asthma	2.74e-05	0.000194	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—ARG1—asthma	2.74e-05	0.000678	CbGpPWpGaD
Salicylate-sodium—Abdominal pain—Methylprednisolone—asthma	2.74e-05	0.000194	CcSEcCtD
Salicylate-sodium—Decreased appetite—Dexamethasone—asthma	2.74e-05	0.000194	CcSEcCtD
Salicylate-sodium—Decreased appetite—Betamethasone—asthma	2.74e-05	0.000194	CcSEcCtD
Salicylate-sodium—Infection—Prednisone—asthma	2.73e-05	0.000193	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Hydrocortisone—asthma	2.72e-05	0.000192	CcSEcCtD
Salicylate-sodium—Fatigue—Betamethasone—asthma	2.72e-05	0.000192	CcSEcCtD
Salicylate-sodium—Fatigue—Dexamethasone—asthma	2.72e-05	0.000192	CcSEcCtD
Salicylate-sodium—Shock—Prednisone—asthma	2.7e-05	0.000191	CcSEcCtD
Salicylate-sodium—Pain—Betamethasone—asthma	2.69e-05	0.000191	CcSEcCtD
Salicylate-sodium—Pain—Dexamethasone—asthma	2.69e-05	0.000191	CcSEcCtD
Salicylate-sodium—Tachycardia—Prednisone—asthma	2.68e-05	0.00019	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Prednisone—asthma	2.65e-05	0.000188	CcSEcCtD
Salicylate-sodium—Asthenia—Hydrocortisone—asthma	2.65e-05	0.000187	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	2.62e-05	0.000649	CbGpPWpGaD
Salicylate-sodium—Anorexia—Prednisone—asthma	2.62e-05	0.000185	CcSEcCtD
Salicylate-sodium—Pruritus—Hydrocortisone—asthma	2.61e-05	0.000185	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Dexamethasone—asthma	2.6e-05	0.000184	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Betamethasone—asthma	2.6e-05	0.000184	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Betamethasone—asthma	2.58e-05	0.000182	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Dexamethasone—asthma	2.58e-05	0.000182	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Triamcinolone—asthma	2.56e-05	0.000181	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Methylprednisolone—asthma	2.55e-05	0.000181	CcSEcCtD
Salicylate-sodium—Diarrhoea—Hydrocortisone—asthma	2.52e-05	0.000179	CcSEcCtD
Salicylate-sodium—Urticaria—Betamethasone—asthma	2.5e-05	0.000177	CcSEcCtD
Salicylate-sodium—Urticaria—Dexamethasone—asthma	2.5e-05	0.000177	CcSEcCtD
Salicylate-sodium—Dizziness—Prednisolone—asthma	2.5e-05	0.000177	CcSEcCtD
Salicylate-sodium—Asthenia—Triamcinolone—asthma	2.49e-05	0.000176	CcSEcCtD
Salicylate-sodium—Body temperature increased—Dexamethasone—asthma	2.49e-05	0.000176	CcSEcCtD
Salicylate-sodium—Abdominal pain—Betamethasone—asthma	2.49e-05	0.000176	CcSEcCtD
Salicylate-sodium—Abdominal pain—Dexamethasone—asthma	2.49e-05	0.000176	CcSEcCtD
Salicylate-sodium—Body temperature increased—Betamethasone—asthma	2.49e-05	0.000176	CcSEcCtD
Salicylate-sodium—Asthenia—Methylprednisolone—asthma	2.49e-05	0.000176	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—ALOX5AP—asthma	2.48e-05	0.000613	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ALOX15—asthma	2.48e-05	0.000613	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ALDH7A1—asthma	2.48e-05	0.000613	CbGpPWpGaD
Salicylate-sodium—Paraesthesia—Prednisone—asthma	2.46e-05	0.000174	CcSEcCtD
Salicylate-sodium—Pruritus—Triamcinolone—asthma	2.46e-05	0.000174	CcSEcCtD
Salicylate-sodium—Pruritus—Methylprednisolone—asthma	2.45e-05	0.000173	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—asthma	2.45e-05	0.000606	CbGpPWpGaD
Salicylate-sodium—Dizziness—Hydrocortisone—asthma	2.44e-05	0.000173	CcSEcCtD
Salicylate-sodium—Dyspepsia—Prednisone—asthma	2.42e-05	0.000171	CcSEcCtD
Salicylate-sodium—Decreased appetite—Prednisone—asthma	2.39e-05	0.000169	CcSEcCtD
Salicylate-sodium—Rash—Prednisolone—asthma	2.38e-05	0.000168	CcSEcCtD
Salicylate-sodium—Dermatitis—Prednisolone—asthma	2.38e-05	0.000168	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—ARG2—asthma	2.38e-05	0.000588	CbGpPWpGaD
Salicylate-sodium—Diarrhoea—Methylprednisolone—asthma	2.37e-05	0.000168	CcSEcCtD
Salicylate-sodium—Fatigue—Prednisone—asthma	2.37e-05	0.000167	CcSEcCtD
Salicylate-sodium—Headache—Prednisolone—asthma	2.37e-05	0.000167	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—CHAT—asthma	2.36e-05	0.000585	CbGpPWpGaD
Salicylate-sodium—Constipation—Prednisone—asthma	2.35e-05	0.000166	CcSEcCtD
Salicylate-sodium—Vomiting—Hydrocortisone—asthma	2.34e-05	0.000166	CcSEcCtD
Salicylate-sodium—Rash—Hydrocortisone—asthma	2.33e-05	0.000165	CcSEcCtD
Salicylate-sodium—Dermatitis—Hydrocortisone—asthma	2.32e-05	0.000164	CcSEcCtD
Salicylate-sodium—Headache—Hydrocortisone—asthma	2.31e-05	0.000164	CcSEcCtD
Salicylate-sodium—Dizziness—Triamcinolone—asthma	2.3e-05	0.000163	CcSEcCtD
Salicylate-sodium—Dizziness—Methylprednisolone—asthma	2.29e-05	0.000162	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Prednisone—asthma	2.26e-05	0.00016	CcSEcCtD
Salicylate-sodium—Asthenia—Betamethasone—asthma	2.26e-05	0.00016	CcSEcCtD
Salicylate-sodium—Asthenia—Dexamethasone—asthma	2.26e-05	0.00016	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—IL6—asthma	2.25e-05	0.000557	CbGpPWpGaD
Salicylate-sodium—Gastrointestinal pain—Prednisone—asthma	2.24e-05	0.000159	CcSEcCtD
Salicylate-sodium—Nausea—Prednisolone—asthma	2.24e-05	0.000159	CcSEcCtD
Salicylate-sodium—Pruritus—Dexamethasone—asthma	2.23e-05	0.000158	CcSEcCtD
Salicylate-sodium—Pruritus—Betamethasone—asthma	2.23e-05	0.000158	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—asthma	2.21e-05	0.000548	CbGpPWpGaD
Salicylate-sodium—Vomiting—Triamcinolone—asthma	2.21e-05	0.000156	CcSEcCtD
Salicylate-sodium—Vomiting—Methylprednisolone—asthma	2.2e-05	0.000156	CcSEcCtD
Salicylate-sodium—Nausea—Hydrocortisone—asthma	2.19e-05	0.000155	CcSEcCtD
Salicylate-sodium—Rash—Triamcinolone—asthma	2.19e-05	0.000155	CcSEcCtD
Salicylate-sodium—Dermatitis—Triamcinolone—asthma	2.19e-05	0.000155	CcSEcCtD
Salicylate-sodium—Rash—Methylprednisolone—asthma	2.18e-05	0.000155	CcSEcCtD
Salicylate-sodium—Dermatitis—Methylprednisolone—asthma	2.18e-05	0.000154	CcSEcCtD
Salicylate-sodium—Urticaria—Prednisone—asthma	2.18e-05	0.000154	CcSEcCtD
Salicylate-sodium—Headache—Triamcinolone—asthma	2.18e-05	0.000154	CcSEcCtD
Salicylate-sodium—Headache—Methylprednisolone—asthma	2.17e-05	0.000154	CcSEcCtD
Salicylate-sodium—Abdominal pain—Prednisone—asthma	2.17e-05	0.000154	CcSEcCtD
Salicylate-sodium—Body temperature increased—Prednisone—asthma	2.17e-05	0.000154	CcSEcCtD
Salicylate-sodium—Diarrhoea—Betamethasone—asthma	2.16e-05	0.000153	CcSEcCtD
Salicylate-sodium—Diarrhoea—Dexamethasone—asthma	2.16e-05	0.000153	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—ALOX5—asthma	2.11e-05	0.000521	CbGpPWpGaD
Salicylate-sodium—Dizziness—Betamethasone—asthma	2.08e-05	0.000147	CcSEcCtD
Salicylate-sodium—Dizziness—Dexamethasone—asthma	2.08e-05	0.000147	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	2.08e-05	0.000515	CbGpPWpGaD
Salicylate-sodium—Nausea—Triamcinolone—asthma	2.06e-05	0.000146	CcSEcCtD
Salicylate-sodium—Nausea—Methylprednisolone—asthma	2.06e-05	0.000146	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	2.03e-05	0.000503	CbGpPWpGaD
Salicylate-sodium—Hypersensitivity—Prednisone—asthma	2.02e-05	0.000143	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—CARM1—asthma	2.01e-05	0.000497	CbGpPWpGaD
Salicylate-sodium—Vomiting—Dexamethasone—asthma	2e-05	0.000142	CcSEcCtD
Salicylate-sodium—Vomiting—Betamethasone—asthma	2e-05	0.000142	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—asthma	1.99e-05	0.000493	CbGpPWpGaD
Salicylate-sodium—Rash—Betamethasone—asthma	1.99e-05	0.000141	CcSEcCtD
Salicylate-sodium—Rash—Dexamethasone—asthma	1.99e-05	0.000141	CcSEcCtD
Salicylate-sodium—Dermatitis—Betamethasone—asthma	1.98e-05	0.00014	CcSEcCtD
Salicylate-sodium—Dermatitis—Dexamethasone—asthma	1.98e-05	0.00014	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—DCN—asthma	1.98e-05	0.00049	CbGpPWpGaD
Salicylate-sodium—Headache—Dexamethasone—asthma	1.97e-05	0.00014	CcSEcCtD
Salicylate-sodium—Headache—Betamethasone—asthma	1.97e-05	0.00014	CcSEcCtD
Salicylate-sodium—Asthenia—Prednisone—asthma	1.97e-05	0.000139	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—ALOX15—asthma	1.97e-05	0.000487	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ALOX5AP—asthma	1.97e-05	0.000487	CbGpPWpGaD
Salicylate-sodium—Pruritus—Prednisone—asthma	1.94e-05	0.000137	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—ALDH2—asthma	1.93e-05	0.000477	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—asthma	1.9e-05	0.000469	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—DCN—asthma	1.88e-05	0.000465	CbGpPWpGaD
Salicylate-sodium—Diarrhoea—Prednisone—asthma	1.88e-05	0.000133	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—CHAT—asthma	1.88e-05	0.000464	CbGpPWpGaD
Salicylate-sodium—Nausea—Dexamethasone—asthma	1.87e-05	0.000132	CcSEcCtD
Salicylate-sodium—Nausea—Betamethasone—asthma	1.87e-05	0.000132	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—POMC—asthma	1.85e-05	0.000459	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GSTT1—asthma	1.83e-05	0.000454	CbGpPWpGaD
Salicylate-sodium—Dizziness—Prednisone—asthma	1.81e-05	0.000128	CcSEcCtD
Salicylate-sodium—Vomiting—Prednisone—asthma	1.74e-05	0.000123	CcSEcCtD
Salicylate-sodium—Rash—Prednisone—asthma	1.73e-05	0.000122	CcSEcCtD
Salicylate-sodium—Dermatitis—Prednisone—asthma	1.73e-05	0.000122	CcSEcCtD
Salicylate-sodium—Headache—Prednisone—asthma	1.72e-05	0.000122	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—ALB—asthma	1.69e-05	0.000418	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ALOX5—asthma	1.67e-05	0.000414	CbGpPWpGaD
Salicylate-sodium—Nausea—Prednisone—asthma	1.63e-05	0.000115	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—CARM1—asthma	1.6e-05	0.000395	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—DCN—asthma	1.57e-05	0.000389	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CYBA—asthma	1.55e-05	0.000383	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ALDH2—asthma	1.53e-05	0.000379	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—NQO1—asthma	1.52e-05	0.000377	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PARP1—asthma	1.51e-05	0.000375	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ADCY2—asthma	1.49e-05	0.000369	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—asthma	1.48e-05	0.000366	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—POMC—asthma	1.47e-05	0.000364	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTT1—asthma	1.46e-05	0.00036	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—NOS1—asthma	1.42e-05	0.000352	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—ADCY2—asthma	1.41e-05	0.00035	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—ALB—asthma	1.34e-05	0.000332	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PTEN—asthma	1.29e-05	0.000319	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GSTP1—asthma	1.27e-05	0.000314	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—HMOX1—asthma	1.25e-05	0.00031	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ITPR1—asthma	1.25e-05	0.000309	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CAT—asthma	1.24e-05	0.000306	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—NQO1—asthma	1.21e-05	0.000299	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—ITPR1—asthma	1.19e-05	0.000293	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ADCY2—asthma	1.18e-05	0.000293	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PLA2G4A—asthma	1.17e-05	0.000289	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GSTM1—asthma	1.17e-05	0.000289	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CD86—asthma	1.13e-05	0.000279	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PPP2CA—asthma	1.08e-05	0.000266	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—SMAD3—asthma	1.07e-05	0.000264	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PTEN—asthma	1.02e-05	0.000253	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PPP2CA—asthma	1.02e-05	0.000252	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTP1—asthma	1.01e-05	0.00025	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CCR5—asthma	1e-05	0.000248	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—HMOX1—asthma	9.95e-06	0.000246	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ITPR1—asthma	9.93e-06	0.000246	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CAT—asthma	9.82e-06	0.000243	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PDGFB—asthma	9.52e-06	0.000236	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTM1—asthma	9.27e-06	0.000229	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PLA2G4A—asthma	9.27e-06	0.000229	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PPP2CA—asthma	8.54e-06	0.000211	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—NOS2—asthma	8.49e-06	0.00021	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—POMC—asthma	8.26e-06	0.000204	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—IL6R—asthma	7.63e-06	0.000189	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ALB—asthma	7.53e-06	0.000186	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—NOS3—asthma	7.2e-06	0.000178	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—SERPINE1—asthma	7.15e-06	0.000177	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—RHOA—asthma	6.9e-06	0.000171	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—NOS3—asthma	6.82e-06	0.000169	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PTGS2—asthma	6.58e-06	0.000163	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—POMC—asthma	6.55e-06	0.000162	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CD4—asthma	6.29e-06	0.000156	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ALB—asthma	5.98e-06	0.000148	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PTEN—asthma	5.74e-06	0.000142	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—NOS3—asthma	5.72e-06	0.000141	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PTEN—asthma	5.44e-06	0.000135	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—STAT3—asthma	4.87e-06	0.00012	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PTEN—asthma	4.56e-06	0.000113	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—TGFB1—asthma	4.51e-06	0.000112	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—EGFR—asthma	4.42e-06	0.000109	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—IL6—asthma	3.4e-06	8.41e-05	CbGpPWpGaD
